Table 1.

Clinical and Immunological Features of the Study Groups

Characteristic Controls (n = 20) C-KS (n = 18)AIDS-KS (n = 22)
Sex (M/F)  15/5  18/0  21/1 
Age (mean yr ± SD)  40 ± 10  60 ± 8 30 ± 10  
Risk factor for HIV-1 infection  None  None  18 Homo 4 hetero 
CD3+ cells/μL  1,310 ± 380  1,380 ± 298 1,298 ± 220  
CD16+ cells/μL  264 ± 12 268 ± 12  271 ± 20  
CD4+ cells/μL 780 ± 104  750 ± 106  325 ± 206 
CD8+ cells/μL  319 ± 140  324 ± 111 750 ± 179 
Characteristic Controls (n = 20) C-KS (n = 18)AIDS-KS (n = 22)
Sex (M/F)  15/5  18/0  21/1 
Age (mean yr ± SD)  40 ± 10  60 ± 8 30 ± 10  
Risk factor for HIV-1 infection  None  None  18 Homo 4 hetero 
CD3+ cells/μL  1,310 ± 380  1,380 ± 298 1,298 ± 220  
CD16+ cells/μL  264 ± 12 268 ± 12  271 ± 20  
CD4+ cells/μL 780 ± 104  750 ± 106  325 ± 206 
CD8+ cells/μL  319 ± 140  324 ± 111 750 ± 179 

The immunologic profile shows similar values of lymphocyte subpopulations in C-KS patients in comparison to normal donors, whereas AIDS-KS patients show abnormalities (see text for statistical analysis). Results are given as the mean (M) ± standard deviations (SD).

Abbreviations: n, number; yr, years of age.

or Create an Account

Close Modal
Close Modal